IMRT in the treatment of locally advanced or inoperable NSCLC in the pre-durvalumab era: clinical outcomes and pattern of relapses, experience from the Oscar Lambret Center.

Front Oncol · 2023 · PMC10554937 · PMID 37810972

Europe PMC DOI

hedged sentence

0.0590

closest p · 1.2× alpha

0.0590

boldest claim

The sentences

close to significancep=0.059so close (0.05 < p ≤ 0.1)

However, lymph node involvement (N0-N1 vs N2-N3) was close to significance with a hazard ratio of 2.46 (0.97-6.25, p=0.059).

also in 610 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.